A Review on European Union New Medical Device Regulations-2017
Author(s) -
U. S. Lakshmi,
K Sowjanya,
K. Revathi,
Shailaja Pashikanti,
J. Vijaya Ratna,
B. A. Daniel,
S. Prashanth
Publication year - 2018
Publication title -
pharmatutor
Language(s) - English
Resource type - Journals
eISSN - 2394-6679
pISSN - 2347-7881
DOI - 10.29161/pt.v6.i2.2018.9
Subject(s) - directive , european union , medical device , member states , identification (biology) , audit , member state , sanctions , business , medicine , political science , accounting , computer science , law , international trade , biomedical engineering , botany , biology , programming language
The New Medical Device Regulations of European Union replace the E.U’s current Medical Device Directive (93/42/EEC) and the E.U’s Directive on Active Implantable Medical Devices (90/385/EEC) According to the draft document, NB’s would be placed under a strict regimen of super vision, although it remains unclear whether the intended sanctions could be implemented against the will of a Member State, should the need occur. The qualification requirements for auditing and reviewing NB staff are steeply increased. Greater emphasis will be placed on clinical data and the Clinical Evaluation. For implantable medical devices and Class III devices clinical investigations will be expected since equivalence will generally no longer be an acceptable approach, although some exceptions can be made. The proposed MDR attempts to make more transparent the periods for review by various parties for different activities. Implementation of Unique device identification helpful for the unambiguous identification of a specific device on the market.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom